Allergic disease
MONDO:0005271An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.
Also known as: allergic disease or disorder, allergic form of disease or disorder, allergic form of immune system disease, allergic reaction, allergic response, allergy, disorder of type I hypersensitivity, type I hypersensitivity disease
968 clinical trials for this condition and its sub-types, 179 tagged with Allergic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic disease
-
Atopic eczema 467 trials · 480 incl. sub-types
3 sub-types
- Allergic contact dermatitis 10 trials Sub-types →
- Allergic urticaria 3 trials · 5 incl. sub-types Sub-types →
- Allergic cutaneous vasculitis 1 trial
-
Allergic respiratory disease 2 trials · 220 incl. sub-types
4 sub-types
- Allergic rhinitis 97 trials · 142 incl. sub-types Sub-types →
- Allergic asthma 41 trials Sub-types →
- Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types Sub-types →
- Allergic bronchopulmonary aspergillosis 15 trials Sub-types →
-
Food allergy 115 trials
-
Drug allergy 35 trials
-
Eye allergy 2 trials · 20 incl. sub-types
2 sub-types
- Atopic conjunctivitis 19 trials Sub-types →
- Allergic contact dermatitis of eyelid 0 trials
-
Atopic IgE-mediated allergic disorder 13 trials
-
Venom allergy 12 trials
-
Gastrointestinal allergy 0 trials · 5 incl. sub-types
1 sub-type
-
Alpha-gal syndrome 4 trials
-
Allergic otitis media 0 trials
1 sub-type
- Acute allergic serous otitis media 0 trials
-
Latex allergy 0 trials
-
Vulvovaginitis, allergic seminal 0 trials
Most studied deeper sub-types
-
New hope for rare blood cancer: experimental drug targets mast cells
Disease control Recruiting nowThis study tests an experimental drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by blocking a key protein that drives abnormal mast cell growth. About 140 adults with aggre…
Phase 2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could an allergy drug tame COPD Flare-Ups?
Disease control Recruiting nowThis study tests if omalizumab (Xolair), an allergy drug, can reduce serious flare-ups in people with COPD who also have allergies. About 334 participants will receive injections of the drug or a placebo for 12 months. The goal is to see if the drug lowers the number of COPD exac…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Last-Resort access to dupilumab for patients with severe inflammation
Disease control Expanded accessThis program provides compassionate use of dupilumab (Dupixent) for patients with severe type 2 inflammatory disorders who have no other treatment options. It aims to offer access to this drug outside of a clinical trial. The program is already approved for marketing.
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug BBD-1 shows promise for painful skin and kidney disease
Disease control Recruiting nowThis study tests a new drug, BBD-1, against standard steroids for IgA vasculitis, a disease that causes purple spots on the skin, joint pain, and can damage the kidneys. The trial will enroll 30 adults with confirmed IgA vasculitis. The goal is to see if BBD-1 can clear skin spot…
Phase 2 • Sponsor: Qifeng Zhang • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
A Three-Point message could boost medication adherence in chronic disease
Disease control Recruiting nowThis study tests whether a simple, standardized, and repeated message from healthcare professionals can improve how well patients with chronic diseases follow their treatment plans. About 1,200 adults with chronic conditions will receive this message during regular consultations.…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Apple a day keeps the allergy away? new trial tests raw apple therapy
Disease control Recruiting nowThis study tests whether eating small, increasing amounts of raw apple can reduce mouth allergy symptoms in people who are allergic to both birch pollen and apples. 110 participants will eat either real apple or a placebo over 9 months. The goal is to see if they can tolerate a l…
Phase 3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for chronic hives? experimental drug lesigercept enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug called lesigercept in 150 adults with chronic spontaneous urticaria (hives lasting 6+ months) that aren't controlled by standard antihistamines. Participants receive either lesigercept or a placebo injection. The main goal is to see if lesigercept redu…
Phase 2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Smart spacer could help kids breathe easier
Disease control Recruiting nowThis study tests whether a new digital spacer (Whizz) helps children aged 5-16 with asthma use their inhaler correctly and stick to their medication, compared to a standard spacer. Researchers will also look for biomarkers in blood and breath to improve diagnosis and understand h…
Sponsor: Luxembourg Institute of Health • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Fiber fix for asthma? new study tests gut health link
Disease control Recruiting nowThis study tests whether adding soluble fiber (inulin) to the diet can improve asthma control in children aged 6 to 17. Participants will take a fiber or placebo drink for several weeks. Researchers will check asthma symptoms and analyze gut and nasal microbes to see if diet chan…
Phase 2 • Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New liquid diet trial aims to help patients with severe bowel disorders
Disease control Recruiting nowThis study is testing an upgraded amino acid-based nutritional supplement for 30 children and adults who have severe gut problems like inflammatory bowel disease, short bowel syndrome, or severe allergies. Participants will use the supplement as part of their diet for 28 days. Re…
Sponsor: Nutricia UK Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Fast vs. slow: which oral allergy treatment works best for kids?
Disease control Recruiting nowThis study compares two ways of giving oral immunotherapy to children aged 6–16 with milk or egg allergy. One method uses daily increasing doses over a week ('rush'), while the other uses doses every two weeks ('conventional'). The goal is to see which is safer and more effective…
Phase 2/3 • Sponsor: Pablo Rodríguez del Rio • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a higher dose of xolair beat food allergies?
Disease control Recruiting nowThis study tests if higher doses of omalizumab (Xolair) can help people with food allergies tolerate more of their trigger foods. Thirty participants with allergies to peanut, cashew, walnut, egg, or milk will receive either 5 mg/kg or 15 mg/kg of omalizumab for 16 weeks. The goa…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a 9-Minute chat help black adults breathe easier?
Disease control Recruiting nowThis study tests a short, scripted conversation between doctors and Black adults with uncontrolled asthma. The goal is to help patients and doctors make decisions together about asthma medicines. Researchers will enroll 400 adults at community health centers to see if this approa…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New allergy shot could take the sting out of bee and wasp allergies
Disease control Recruiting nowThis study is testing an allergy immunotherapy called Beltaven for people allergic to bee or wasp stings. Researchers want to see if a 3-week series of shots helps patients tolerate stings without a severe reaction. The study will follow 27 participants aged 14 and older who have…
Sponsor: Probelte Pharma S.L.U. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New blood test may take the guesswork out of shrimp allergy diagnosis in kids
Diagnosis Recruiting nowThis study will check if measuring IgE antibodies to two shrimp proteins (tropomyosin and hemocyanin) in the blood can accurately diagnose shrimp allergy in children. About 129 kids with suspected shrimp allergy will take part. They will have a food challenge, skin test, and bloo…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Needle-Free scans could spot silent liver damage
Diagnosis Recruiting nowNonalcoholic fatty liver disease affects many people with obesity or type 2 diabetes, and its more serious form, nonalcoholic steatohepatitis, can lead to cirrhosis and liver failure. Doctors currently rely on liver biopsy to judge how severe the disease is, but that test is inva…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Modified pork could revolutionize Alpha-Gal allergy testing
Diagnosis Recruiting nowThis study tests whether specially modified pork (alpha-gal knockout) causes fewer allergic reactions than regular pork in people with alpha-gal syndrome. Each of the 160 participants will eat both types of pork on different days to see which one is safer for diagnosis. The goal …
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New study aims to crack the code on cephalosporin allergies
Diagnosis Recruiting nowThis study looks for better ways to diagnose allergies to cephalosporin antibiotics, which are commonly used but can cause serious reactions. Researchers will test 300 adults with a history of possible allergic reactions using skin tests and controlled drug challenges. The goal i…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
New 15-Minute test could stop superbug outbreaks in hospitals
Diagnosis Recruiting nowThis study evaluates a rapid diagnostic test that can detect Candida auris, a drug-resistant fungus, in about 15 minutes. Researchers will compare the test's accuracy against standard lab methods using samples from 554 patients. The goal is to help hospitals quickly identify and …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Blood test could end guesswork in amoxicillin allergy diagnosis
Diagnosis Recruiting nowThis study is testing a new blood test called the T-cell activation test to see if it can more accurately diagnose amoxicillin allergy. Researchers will compare results from 300 people with suspected allergy and those without. If the test works well, it could replace less reliabl…
Sponsor: University Hospital, Antwerp • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
Prevention Recruiting nowThis study investigates whether a mother's consumption or avoidance of peanut and egg during pregnancy and breastfeeding influences her baby's risk of developing allergies to these foods. Pregnant women are assigned to either eat or avoid peanut and egg from 27 weeks of pregnancy…
Sponsor: University of Rochester • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Could a daily probiotic shield babies from allergies?
Prevention Recruiting nowThis study tests whether a daily probiotic supplement (Bifidobacterium lactis XLTG11) can lower the chance of allergies in healthy infants under 3 years old who are at higher risk. Over 180 days, researchers will track allergy symptoms and analyze gut bacteria changes. The goal i…
Phase 2 • Sponsor: Min-Tze LIONG • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Fish oil in pregnancy may cut childhood asthma risk, major trial launches
Prevention Recruiting nowThis study is testing whether taking high-dose fish oil supplements during pregnancy can prevent asthma and persistent wheezing in early childhood. The trial will enroll 2000 pregnant Danish women with low blood levels of omega-3s. Participants take fish oil or placebo capsules d…
Phase 3 • Sponsor: Professor Klaus Bønnelykke • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Prenatal vitamin d: a simple step to stop childhood asthma?
Prevention Recruiting nowThis study is testing whether taking a higher dose of vitamin D during pregnancy can prevent asthma and persistent wheezing in children up to age 3. Researchers will give 2000 pregnant women either vitamin D or a placebo daily from week 22-26 of pregnancy until one week after del…
Phase 3 • Sponsor: Professor Klaus Bønnelykke • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Can an RNA shot teach the immune system to ignore cedar pollen?
Symptom relief Recruiting nowThis early-stage trial tests an experimental RNA immunotherapy called ITI-9001 in adults with Japanese cedar pollen allergy. The treatment aims to retrain the immune system to reduce allergic reactions. Researchers are primarily checking safety and how well people tolerate the sh…
Phase 1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 21, 2026 13:00 UTC
-
The whitening wars: peroxide vs Peroxide-Free bleaching put to the test
Symptom relief Recruiting nowResearchers at Minia University are comparing two in-office tooth bleaching systems: one that uses peroxide and one that does not. Fifty adults aged 18 to 45 with healthy front teeth will receive one of the two treatments. Over six months, the team will measure how white the teet…
Sponsor: Minia University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a puff of inhaled epinephrine stop severe allergic reactions?
Symptom relief Recruiting nowThis study tests if inhaled epinephrine can quickly ease systemic allergic reactions that happen during allergy testing or treatment. About 100 people aged 12 and older with known allergies will take part. The goal is to see how fast symptoms improve, aiming for a safer and easie…
Phase 1 • Sponsor: Dr. George Luciuk • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New study aims to take the fear out of allergy testing for children
Symptom relief Recruiting nowThis study tests whether child life services—special support to help kids cope with medical procedures—can reduce pain and fear during skin prick allergy tests. About 140 children aged 1-18 will either receive this extra support or standard care. Researchers will measure pain, ho…
Sponsor: Children's Hospital of Fudan University • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Nasal spray vs. needle: new study tests easier allergy rescue
Symptom relief Recruiting nowThis study looks at the safety of a nasal spray called neffy compared to a standard epinephrine shot for treating allergic reactions. It involves 600 people aged 4 and older who have an allergic reaction during a food challenge or allergy shot session. The goal is to see if the s…
Phase 4 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
EATING YOUR WAY TO CLEARER SKIN? NEW STUDY TESTS DIET FOR ECZEMA
Symptom relief Recruiting nowThis study tests whether a diet low in saturated fats and rich in whole grains, fruits, and vegetables can reduce the severity of atopic dermatitis (eczema) in young adults. Researchers will track changes in skin symptoms and barrier function over two months. The goal is to see i…
Sponsor: National University of Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Real-World allergy treatment under the microscope
Symptom relief Recruiting nowThis study tracks how adults with grass pollen allergy use Grassmuno® in everyday medical practice. Researchers will monitor treatment adherence and injection schedules over two years. The goal is to understand how well patients stick with the therapy and how it controls their sy…
Sponsor: Allergy Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
New dental tech aims to ease pain for kids with sensitive teeth
Symptom relief Recruiting nowThis study compares two computer-assisted anesthesia methods—intraosseous and infiltration—to see which works better for children aged 6-12 with Molar-Incisor Hypomineralization (MIH), a condition causing sensitive teeth. Researchers will measure pain, stress, and heart rate in 3…
Sponsor: Ankara Yildirim Beyazıt University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Diet before surgery may cut pain and opioid use, new trial hopes to prove
Symptom relief Recruiting nowThis study tests whether eating a diet very low in polyamines (natural compounds found in many foods) for a week before and after major abdominal surgery can lower pain levels. Researchers will compare pain scores and painkiller use in 278 adults who either follow the special die…
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Whitening without the ouch? study tests best way to brighten smiles
Symptom relief Recruiting nowThis study looks at whether using a tooth-whitening gel in one long session or several short sessions changes how much tooth pain people feel and how white their teeth get. About 60 adults with darker teeth will receive one of two common whitening gels. Researchers will measure p…
Sponsor: King Abdullah University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 17:17 UTC
-
Scientists launch national study to track immune weakness linked to severe COVID
Knowledge-focused Recruiting nowThis study follows 500 adults in France who have either a genetic defect or autoantibodies that weaken their type I interferon immune response. Researchers will collect blood samples and health data over 1 to 4 years to track infections, autoimmune diseases, and cancers. The goal…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
150,000 children to be tracked from birth to old age in massive health study
Knowledge-focused Recruiting nowResearchers are building a long-term health study of 150,000 children born in Victoria, Australia, and their parents. The study follows participants from birth over their lifetime, collecting data on health, development, and environment through surveys, biosamples, and linked rec…
Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists seek clues on white blood cell behavior in allergies and parasites
Knowledge-focused Recruiting nowThis study aims to understand how and why eosinophils (a type of white blood cell) become active in conditions like allergies, asthma, and parasitic infections. Researchers will observe up to 800 people aged 1 to 100 with high eosinophil levels. No experimental treatments are giv…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Could your soap and food be making you sick? new study investigates
Knowledge-focused Recruiting nowThis study looks at how common chemicals in personal care products, processed foods, and synthetic materials affect skin, gut, and airway health. One hundred twenty healthy adults will stay in a controlled hospital room for two 7-day periods—one with filtered air and pure product…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can a simple test predict peanut allergy reactions?
Knowledge-focused Recruiting nowThis study aims to find biomarkers—signs in the body—that can tell if a child will have an allergic reaction to peanut during a feeding test. It will involve 500 children aged 1 to 17 who are suspected of having a peanut allergy. No treatment is given; the goal is to better under…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can a City-Wide asthma registry unlock new discoveries?
Knowledge-focused Recruiting nowThis study creates a registry of people with asthma who live in urban areas, including children and adults. The goal is to gather detailed information about their asthma and allergy characteristics. This database will serve as a pool of potential participants for future research …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Scientists hunt for hidden clues to drug reactions in the blood
Knowledge-focused Recruiting nowThis study aims to find new markers in the blood that appear during non-allergic drug infusion reactions. Healthy adults will receive the antibiotic vancomycin and have blood samples taken to measure drug levels and other substances. The goal is to better understand and predict t…
Phase 1/2 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Tooth color may reveal hidden sensitivity in Children's molars
Knowledge-focused Recruiting nowThis study explores whether the color of a 'cheese molar' — a tooth with a chalky white or yellow-brown spot — can predict how sensitive it is to air or touch. Researchers will photograph and scan the affected molars of children aged 5 to 8, then test sensitivity with a gentle ai…
Sponsor: University of Basel • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
10,000 volunteers needed to unlock allergy mysteries
Knowledge-focused Recruiting nowThis study aims to collect blood, nasal fluid, skin cells, urine, and medical data from 10,000 people aged 3 to 100 with allergies, asthma, eczema, or sinus issues. Participants will have up to 3 years of follow-up visits and questionnaires. The goal is to create a large reposito…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New Low-Dose food challenge could make FPIES diagnosis safer
Knowledge-focused Recruiting nowThis study is testing a new, low-dose food challenge given over several days to diagnose FPIES, a food allergy that causes vomiting and diarrhea. Researchers want to find the safest dose that can still trigger symptoms in people with FPIES. The study involves 72 people aged 1 to …
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New quick tests may unlock secrets of brain disease
Knowledge-focused Recruiting nowThis study looks at whether new, quick tests that measure how fast people can move can help doctors diagnose brain diseases like Alzheimer's and predict recovery after a stroke. Researchers will test 129 adults aged 40-85 with stroke or memory problems. The goal is to see if thes…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
530 hay fever volunteers needed to stop thunderstorm asthma attacks
Knowledge-focused Recruiting nowThis study is looking for 530 adults with hay fever in South-Eastern Australia to help create a tool that predicts thunderstorm asthma. Participants will have allergy and lung function tests, then track their symptoms during spring for two years. The goal is to find warning signs…
Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could your child's penicillin allergy be a mistake? new study tests in-office solution
Knowledge-focused Recruiting nowThis study looks at whether private practice doctors can safely give children with suspected mild delayed allergies to beta-lactam antibiotics (like amoxicillin) a direct oral challenge. The challenge involves giving the child a small dose of the antibiotic and watching for a rea…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists probe lymph nodes to unlock cat allergy mysteries
Knowledge-focused Recruiting nowThis study looks at immune cells in the lymph nodes of 16 cat-allergic adults. Half are on long-term allergy shots (immunotherapy), half are not. Researchers will give a small cat allergen injection and then sample lymph nodes and blood to see how many analyzable cells they can c…
Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Scientists investigate key immune cells in severe drug allergy
Knowledge-focused Recruiting nowThis study aims to understand how a type of white blood cell called eosinophils contributes to DRESS syndrome, a severe and potentially life-threatening drug allergy. Researchers will compare blood and skin samples from 80 adults with DRESS, other drug rashes, and healthy volunte…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Mali allergy study seeks clues in gut and skin germs
Knowledge-focused Recruiting nowThis study examines how germs living on and in the body, along with environmental factors like pollution, may influence allergic diseases such as asthma and eczema in people living in Mali. Researchers will collect samples and health information from 288 participants, both with a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Ant venom allergy treatment: does it last?
Knowledge-focused Recruiting nowThis study looks at how well venom immunotherapy protects people with Jack Jumper ant allergy years after treatment stops. About 100 adults who completed 3-6 years of therapy and have been off treatment for at least 18 months will have a supervised sting challenge and blood test.…
Phase 4 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
2,500 volunteers needed to unlock allergy mysteries
Knowledge-focused Recruiting nowStanford University is recruiting 2,500 people with possible allergies to improve how allergies are diagnosed. Researchers will study skin test responses and look at genetic and immune system factors. This study does not test any new treatment, but aims to deepen knowledge of all…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New allergy test could be done with just a urine sample
Knowledge-focused Recruiting nowThis study is testing a new method to measure allergy-related substances (IgE) in blood and urine. Researchers want to see if this new technique works as well as current tests. About 1,376 children and adults with allergies will provide blood and urine samples during routine visi…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Tourette syndrome study seeks to uncover hidden sensory struggles
Knowledge-focused Recruiting nowThis study aims to better understand sensory symptoms in adults with Tourette syndrome or chronic tic disorders. About 214 participants will fill out yearly questionnaires about urges, attention, mood, and quality of life. The goal is to gather information, not to test a treatmen…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New allergy drug Exl-111 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage trial is testing the safety of a new drug called Exl-111 in 70 healthy volunteers. The study has two parts: one where people get a single dose, and another where they get multiple doses. Some participants will receive the drug, some a placebo, and some an existin…
Phase 1 • Sponsor: Excellergy Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can treating your mind and allergies together improve symptoms?
Knowledge-focused Recruiting nowThis study explores whether people who seek help for both their allergies and their mental health (like anxiety or depression) have better control over their symptoms. Researchers will look at health records from 200,000 adults over several years. The goal is to understand if com…
Sponsor: QHSLab, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
School air study aims to uncover hidden triggers for Kids' allergies
Knowledge-focused Recruiting nowThis study looks at how indoor air and dust pollutants in classrooms impact children's allergies and lung function. Researchers will monitor 100 children, comparing those with allergies to those without, using questionnaires, allergy tests, and breathing tests. The goal is to ide…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Massive study seeks genetic roots of allergies and immune problems
Knowledge-focused Recruiting nowThis study aims to find the genetic causes behind certain allergic and immune system disorders. Researchers will collect blood, saliva, and tissue samples from up to 10,000 people of all ages, along with some family members. No treatments are given; the goal is simply to learn mo…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Scientists probe hidden IgE variants to unlock allergy mysteries
Knowledge-focused Recruiting nowThis study looks at different forms of IgE (a protein involved in allergic reactions) in healthy volunteers and people with conditions like severe allergies, chronic hives, mastocytosis, and immune deficiencies. Researchers aim to understand how these IgE variations relate to hea…
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New study probes why some babies develop eczema: Self-Antibodies under the microscope
Knowledge-focused Recruiting nowThis study looks at whether babies born with certain self-reactive antibodies are more likely to develop eczema. Researchers will test umbilical cord blood from 500 newborns—some with a family history of allergies or eczema, some without—and follow them for two years. The goal is…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Watching yourself parent: new study aims to boost Kids' emotional health
Knowledge-focused Recruiting nowThis study is testing a program called VIPP-SD, where parents watch video recordings of themselves with their child and get coaching to improve their sensitivity and discipline. The goal is to help children ages 2 to 6 develop better emotional and social skills. Researchers will …
Sponsor: ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Scientists hunt for hidden links between eczema and food allergies
Knowledge-focused Recruiting nowThis study collects blood and skin samples from 200 people with eczema, food allergies, or neither. Researchers will analyze these samples to find shared genetic or biochemical signals. The goal is to better understand how these conditions are connected, which could lead to bette…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Stanford launches food allergy registry to speed up clinical trial enrollment
Knowledge-focused Recruiting nowThis study is a registry that collects contact information from people of all ages who are interested in joining future clinical trials for allergies or asthma. No treatments or tests are given—it simply helps researchers find volunteers for upcoming studies. Anyone from 0 to 100…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Scientists hunt for noninvasive biomarkers to spare children from repeated endoscopies
Knowledge-focused Recruiting nowThis study aims to find noninvasive biomarkers—like substances in urine, blood, or saliva—that can accurately detect active eosinophilic esophagitis in children. Currently, diagnosis and monitoring require repeated endoscopies with biopsies under anesthesia. Researchers will coll…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:14 UTC